Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant

Adults with relapsed/refractory acute lymphoblastic leukemia have a poor prognosis. While current immunotherapies are promising, they are toxic, with graft-versus-host disease a major complication of allogeneic therapy. Here, we report a patient with high-risk relapsed/refractory Philadelphia chromo...

Descripción completa

Detalles Bibliográficos
Autores principales: Maharaj, Dipnarine, Vianna, Pedro, DeCarvalho, Gabriel, Pourkalbassi, Delaram, Hickey, Christopher, Gouvea, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554698/
https://www.ncbi.nlm.nih.gov/pubmed/31245042
http://dx.doi.org/10.2144/fsoa-2019-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554698/
https://www.ncbi.nlm.nih.gov/pubmed/31245042
http://dx.doi.org/10.2144/fsoa-2019-0009

Ejemplares similares